comparemela.com
Home
Live Updates
Telix (ASX:TLX) Advances in Prostate Cancer Treatment : comparemela.com
Telix (ASX:TLX) Advances in Prostate Cancer Treatment
Telix Pharmaceuticals (ASX: TLX) has completed the CUPID study, a Phase I trial on its investigational drug TLX592 for prostate cancer patients
Related Keywords
Davidn Cade ,
,
Telix Pharmaceuticals ,
Sonic Healthcare ,
comparemela.com © 2020. All Rights Reserved.